MONTREAL, May 10, 2019 /CNW Telbec/ - Pharmascience Inc. is proud to announce the launch of its new division in Montreal, Royalmount Laboratories. Royalmount Laboratories specializes in contract research services for both local and international companies. This new division leverages Pharmascience's strength in bioanalytical operations with a new competency in Cannabis testing for third parties.
"Pharmascience has been testing pharmaceutical products for over 35 years and doing its own bioanalysis on clinical trials for over 25 years. Offering our expertise and regulatory knowledge in analytical and bioanalytical testing to now help clients obtain cannabis testing is a bold new business expansion driven by our continued internal drive to be at the technical foreground of new markets." said David Goodman, Chief Executive Officer at Pharmascience Inc.
In March 2019, Pharmascience's licence to test cannabis was transitioned to the new Cannabis Regulations. Fully equipped with state-of-the-art equipment supplied by Shimadzu Corporation, the cannabis testing laboratory has the capability and capacity to perform all Health Canada required tests, including the full spectrum of pesticides in both dried flower and oil products with Pharmascience's usual turnaround times.
"Our existing bioanalytical business has expanded significantly this past year. We completed a Food and Drug Administration audit confirming that our procedures meet FDA regulatory requirements in 2018. We are very excited to add cannabis testing to complement our existing bioanalytical operation. We hope to become Quebec's premier testing laboratory in the very near future." added Adrien Musuku, Royalmount Laboratories Director of Operations. The bioanalytical operation is currently working with external clients for the biological drug quantification in preclinical and clinical studies.
For further information and inquiries, please visit our website http://royalmountlaboratories.com/.
About Pharmascience Inc.
Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately-owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries. Ranked 56th among Canada's top 100 Research & Development (R&D) investors with over $43 million invested in 2018, Pharmascience Inc. is the 4th largest manufacturer of over-the-counter generic drugs in the country.
Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. Pharmascience, through its Royalmount Laboratories division also specializes in contract research services.
In 2018, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience's total donations of essential medicine is close to $70 million.
For more information, please visit www.pharmascience.com.
SOURCE Pharmascience Inc.
For further information: For all media requests: Valérie Piuze, Communications Manager, Tel.: 514-340-9800, ext. 7696, MediaInquiries@pharmascience.com